Active substance:
- Canarypox virus, strain vCP1533, expressing haemagglutinin gene of Influenza A virus subtype H3N8 (A/equine/Newmarket/2/1993), Live
Route of administration:
-
Intramuscular use
Pharmaceutical form:
-
Powder and solvent for suspension for injection
Target species:
-
Horse